Kimelman & Baird, LLC ownership in BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Kimelman & Baird, LLC
Latest Disclosed Ownership	15,525 shares
Latest Disclosed Value	$ 941,592

On May 13, 2026 - Kimelman & Baird, LLC filed a 13F-HR form disclosing ownership of 15,525 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $813,820 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 15,525 shares of Bristol-Myers Squibb Company. This represents a change in shares of 0.00% during the quarter. The current value of the position is $736,351 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-13	2026-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	15,525	0	0.00	942	12.43	0.0775
2026-02-06	2025-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	15,525	-5,072	-24.62	837	-9.81	0.0643
2025-11-25	2025-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	20,597	-650	-3.06	929	-5.60	0.0725
2025-08-12	2025-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	21,247	-100	-0.47	984	-24.44	0.0801
2025-05-13	2025-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	21,347	0	0.00	1,302	7.79	0.1106
2025-02-10	2024-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	21,347	0	0.00	1,207	9.33	0.0960
2024-11-15	2024-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	21,347	-1,085	-4.84	1,104	18.58	0.0881
2024-08-19	2024-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	22,432	8,942	66.29	932	3.33	0.0768
2021-08-17	2021-06-30	13F	Bristol Myers Squibb	cs	110122108	13,490	-30,217	-69.14	901	-59.34	0.0803
2019-12-10	2019-09-30	13F	Bristol Myers Squibb	cs	110122108	43,707	-161	-0.37	2,216	11.41	0.3073
2019-11-22	2019-06-30	13F	Bristol Myers Squibb	cs	110122108	43,868	-13,635	-23.71	1,989	-27.49	0.2767
2019-07-02	2019-03-31	13F	Bristol Myers Squibb	cs	110122108	57,503	0	0.00	2,743	-8.23	0.3946
2019-02-15	2018-12-31	13F	Bristol Myers Squibb	cs	110122108	57,503	0	0.00	2,989	-16.27	0.4650
2019-01-30	2018-09-30	13F	Bristol Myers Squibb	cs	110122108	57,503	0	0.00	3,570	12.19	0.4500
2019-01-24	2018-06-30	13F	Bristol Myers Squibb	cs	110122108	57,503	-1,245	-2.12	3,182	-11.61	0.4177
2018-03-06	2017-12-31	13F	Bristol Myers Squibb	cs	110122108	58,748	1,192	2.07	3,600	-1.88	0.5117
2018-01-02	2017-09-30	13F	Bristol Myers Squibb	cs	110122108	57,556	-1,192	-2.03	3,669	12.10	0.5469
2017-08-22	2017-06-30	13F	Bristol Myers Squibb	COM	110122108	58,748	-9,000	-13.28	3,273	-11.16	0.4960
2017-05-17	2017-03-31	13F	Bristol-Myers Squibb	COM	110122108	67,748	1,092	1.64	3,684	-5.42	0.5611
2017-04-10	2016-12-31	13F	Bristol Myers Squibb	COM	110122108	66,656	1,878	2.90	3,895	11.51	0.6531
2016-12-13	2016-09-30	13F	Bristol Myers Squibb	COM	110122108	64,778	1	0.00	3,493	-26.69	0.6141
2016-08-16	2016-06-30	13F	Bristol Myers Squibb	COM	110122108	64,777	2	0.00	4,765	15.15	0.8710
2016-05-13	2016-03-31	13F	Bristol Myers Squibb	COM	110122108	64,775	462	0.72	4,138	-6.46	0.7730
2016-02-12	2015-12-31	13F	Bristol Myers Squibb	COM	110122108	64,313	-661	-1.02	4,424	2.34	0.8319
2015-08-12	2015-06-30	13F	Bristol Myers Squibb	cs	110122108	64,974	1,185	1.86	4,323	5.05	0.7373
2015-05-12	2015-03-31	13F	Bristol Myers Squibb	cs	110122108	63,789	-95	-0.15	4,115	9.12	0.7504
2015-02-12	2014-12-31	13F	Bristol Myers Squibb	cs	110122108	63,884	0	0.00	3,771	15.36	0.6796
2014-11-13	2014-09-30	13F	Bristol Myers Squibb	COM	110122108	63,884	0	0.00	3,269	5.49	0.6179
2014-08-14	2014-06-30	13F	Bristol Myers Squibb	cs	110122108	63,884	5,500	9.42	3,099	2.18	0.5454
2014-05-20	2014-03-31	13F	Bristol Myers Squibb	cs	110122108	58,384	0	0.00	3,033	-2.26	0.5657
2014-02-13	2013-12-31	13F	Bristol Myers Squibb	COM	110122108	58,384	0	0.00	3,103	14.84	0.5938
2013-11-13	2013-09-30	13F	Bristol Myers Squibb	COM	110122108	58,384	0	0.00	2,702	3.56	0.5397
2013-08-07	2013-06-30	13F	Bristol Myers Squibb	COM	110122108	58,384	58,384		2,609		0.5494

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.